Yıl: 2016 Cilt: 43 Sayı: 1 Sayfa Aralığı: 22 - 26 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study

Öz:
Amaç: Obezite giderek artan bir halk sağlığı ve sosyoe- konomik sorun olmaya devam etmektedir. Sağlıklı bes- lenme ve fiziksel aktivite de dâhil olmak üzere yaşam tar- zı değişiklikleri başarılı kilo kaybı için ilk basamak tedavişekli olarak kabul görülmektedir. Gastrik balon kilo kaybıiçin etkili, geri dönüşümlü ve cerrahi olmayan bir yöntem- dir. Çalışmanın amacı, obez hastalarda intragastrik balo- nun kilo kaybı, lipit profili ve kan şekeri düzenlenmesineetkilerini araştırmaktır.Yöntemler: Bu çalışmada hastaların 35,2 ± 9,6 yaş orta- laması ile 75 ardışık mide balonu hastası (55 Bayan, 20Erkek) çalışmaya dâhil edildi. Çalışma prospektif olarakplanlandı ve hava-dolu mide balonu kontrolleri ayaktanpoliklinikte yapıldı. Bu çalışmada, hastaların uygulamaöncesi vücut kitle indeksi, HbA1c ve lipid profilleri gibi pe- riferik kan parametreleri, kaydedilerek müdahale sonrasıdeğerleri ile karşılaştırıldı. Bulgular: Mide balonu uygulaması için medyan müdaha- le süresi 13 dakika (8-19) idi. Medyan 186 gün (180-211)izlem süresinden sonra, BMI, önemli ölçüde 41,6 ± 6,7den 34,9 ± 6,4 e azalma tespit edildi (p <0,001). Medyanaşırı kilo kaybı (AKK) %33,2 (14-81,1) olarak bulundu.Müdahale öncesi ve sonrası LDL, HDL kolesterol ve TGdüzeyleri karşılaştırıldığında, istatistiksel olarak anlamlıfarklılık bulunmadı. Öte yandan, sadece müdahale öncesive sonrası HbA1c düzeyi istatistiksel olarak anlamlı oldu- ğu saptandı (p = 0,001). Sonuç: İntragastrik balon takılan hastaların takiplerindeBMİ ve HbA1c düzeylerinde anlamlı değişiklikler tespitedildi. Gastrik balonun uzun dönemde yararları için dahaileri çalışmalara ihtiyaç vardır.
Anahtar Kelime:

Konular: Cerrahi

İntragastrik Balonun Vücut Kitle İndeksi, Lipit Profili ve Kan Şekeri Regülasyonu Üzerine Etkileri: Prospektif Çalışma

Öz:
Objective: Obesity remains an increasing public healthand socioeconomic problem. Life style changes includinghealthy diet and physical activity are the first-line therapyfor successful weight loss. The intragastric balloon hasbeen considered as an effective and reversible, non-sur- gical method for weight loss. In this study, we aimed toinvestigate the effects of Intragastric balloon on weightloss, lipid profiles and blood glucose regulation in obesepatientsMethods: 75 consecutive Intragastric balloon patients(55 Female, 20 Male) with a mean age of 35.2±9.6 yearswere included in this study. The study was conductedprospectively and an air-filled intragastric balloon wasintroduced in ambulatory settings. In this study, patientspre-intervention body mass index, peripheral blood pa- rameters such as HbA1c, lipid profiles were recorded andcompared with post-intervention values. Results: The median intervention time for intragastricballoon application was 13 min (8-19). After follow-upperiod of median 186 days (180-211), BMI was reducedsignificantly, 41.6±6.7 vs. 34.9±6.4 kg/m2(p<0.001). Themedian excess weight loss was found to be 33.2% (14- 81.1). There is no statistically significant difference be- tween pre-intervention and post-intervention valuables interms of low-density lipoprotein, high-density lipoprotein,cholesterol and triglycerides levels (p>0.05). On the otherhand, only pre and post-intervention HbA1c level was tobe statistically significant (p=0.001) Conclusion: There was significant change in BMI andHbA1c level with the intervention of intragastric balloonafter follow-up period. For long-term benefit of balloon,further studies are needed.
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Satman I, Omer B, Tutuncu Y, et al; TURDEP-II Study Group. Twelve-year trends in the prevalence and risk fac- tors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013;28:169-180. 2. WHO. Obesity: preventing and managing the global epi- demic. Report of a WHO consultation on obesity. Geneva: World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253. 3. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes Res 1998;6:464. 4. Bays HE. Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res 2004;12:1197-211. 5. Waseem T, Mogensen KM, Lautz DB, et al. Pathophysiology of obesity: why surgery remains the most effective treat- ment. Obes Surg 2007;17:1389-1398. 6. Vrabie CD, Cojocaru M, Waller M, et al. The main histopath- ological gastric lesions in obese patients who underwent sleeve gastrectomy. Dicle Med J 2010;37:97-103. 7. Doldi SB, Micheletto G, Di Prisco F, et al. Intragastric bal- loon in obese patients. Obes Surg 2000;10:578-581. 8. Buzga M, Evzen M, Pavel K, Tomas K, Vladislava Z, Pav- el Z, et al. Effects of the intragastric balloon Medsil® on Weight loss, fat tissue, lipid metabolism, and hormones involved in energy balance. Obes Surg 2014;24:909-915. 9. Genco A, Bruni T, Doldi SB, et al. Bioenterics intragastric Balloon: the Italian experience with 2515 patients. Obes Surg 2005;15:1161-1164. 10. Saruç M, Böler D, Karaarslan M, et al. Intragastric bal- loon treatment of obesity must be combined with bariat- ric surgery: a pilot study in Turkey. Turk J Gastroenterol 2010;21:333-337. 11. Kotzampassi K, Grosomanidis V, Papakostas P, et al. 500 intragastric balloons: What happens 5 years thereafter? Obes Surg 2012;22:896-903. 12. Sekino Y, Imajo K, Sakai E, et al. Time-course of changes of visceral fat area, liver volume and liver fat area during intragastric balloon therapy in Japanese super-obese pa- tients. Intern Med 2011;50:2449-2455. 13. Konopko-Zubrzycka M, Baniukiewicz A, Wroblewski E, et al. The effect of intragastric balloon on plasma ghrelin, leptin, and adiponectin levels in patients with morbid obe- sity. J Clin Endocrinol Metab 2009;94:1644-1649. 14. Crea N, Pata G, Casa DD, et al. Improvement of Metabolic Syndrome following intragastric balloon: 1 year Follow-up Analysis. Obes Surg 2009;19:1084-1088. 15. Forlano R, Ippolito AM, Iacobellis A, et al. Effect of the bioenterics intragastric balloon on weight, insulin resis- tance and liver steatosis in obese patients. Gastrointest En- dosc 2010;71:927-933. 16. Fuller NR, Pearson S, Lau NS, et al. An Intragastric Bal- loon in the Treatment Of Obese Individuals With Metabolic Syndrome: A Randomized Controlled Study. Obesity (Sil- ver Spring) 2013;21:1561-1570. 17. Yasawy MI, Al-Quorain AA, Hussameddin AM. Obe- sity and gastric balloon. J Family Community Med 2014;21:196-199.
APA ERDEM H, ÇETİNKÜNAR S, Aziret M, aktimur r, Özdaş S, TETİŞİR F, YÜREKLİ B (2016). Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study. , 22 - 26.
Chicago ERDEM HASAN,ÇETİNKÜNAR Süleyman,Aziret Mehmet,aktimur recep,Özdaş Sabri,TETİŞİR Fahri,YÜREKLİ Banu Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study. (2016): 22 - 26.
MLA ERDEM HASAN,ÇETİNKÜNAR Süleyman,Aziret Mehmet,aktimur recep,Özdaş Sabri,TETİŞİR Fahri,YÜREKLİ Banu Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study. , 2016, ss.22 - 26.
AMA ERDEM H,ÇETİNKÜNAR S,Aziret M,aktimur r,Özdaş S,TETİŞİR F,YÜREKLİ B Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study. . 2016; 22 - 26.
Vancouver ERDEM H,ÇETİNKÜNAR S,Aziret M,aktimur r,Özdaş S,TETİŞİR F,YÜREKLİ B Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study. . 2016; 22 - 26.
IEEE ERDEM H,ÇETİNKÜNAR S,Aziret M,aktimur r,Özdaş S,TETİŞİR F,YÜREKLİ B "Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study." , ss.22 - 26, 2016.
ISNAD ERDEM, HASAN vd. "Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study". (2016), 22-26.
APA ERDEM H, ÇETİNKÜNAR S, Aziret M, aktimur r, Özdaş S, TETİŞİR F, YÜREKLİ B (2016). Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study. Dicle Tıp Dergisi, 43(1), 22 - 26.
Chicago ERDEM HASAN,ÇETİNKÜNAR Süleyman,Aziret Mehmet,aktimur recep,Özdaş Sabri,TETİŞİR Fahri,YÜREKLİ Banu Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study. Dicle Tıp Dergisi 43, no.1 (2016): 22 - 26.
MLA ERDEM HASAN,ÇETİNKÜNAR Süleyman,Aziret Mehmet,aktimur recep,Özdaş Sabri,TETİŞİR Fahri,YÜREKLİ Banu Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study. Dicle Tıp Dergisi, vol.43, no.1, 2016, ss.22 - 26.
AMA ERDEM H,ÇETİNKÜNAR S,Aziret M,aktimur r,Özdaş S,TETİŞİR F,YÜREKLİ B Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study. Dicle Tıp Dergisi. 2016; 43(1): 22 - 26.
Vancouver ERDEM H,ÇETİNKÜNAR S,Aziret M,aktimur r,Özdaş S,TETİŞİR F,YÜREKLİ B Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study. Dicle Tıp Dergisi. 2016; 43(1): 22 - 26.
IEEE ERDEM H,ÇETİNKÜNAR S,Aziret M,aktimur r,Özdaş S,TETİŞİR F,YÜREKLİ B "Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study." Dicle Tıp Dergisi, 43, ss.22 - 26, 2016.
ISNAD ERDEM, HASAN vd. "Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study". Dicle Tıp Dergisi 43/1 (2016), 22-26.